A prognostic model for platinum‐doublet as second‐line chemotherapy in advanced non‐small‐cell lung cancer patients

Poor prognosis of advanced non‐small‐cell lung cancer (NSCLC) patients and the promising therapeutic effect of platinum urge the oncologists to evaluate the role of platinum doublet as second‐line chemotherapy and establish the definition of platinum sensitivity in NSCLC. We retrospectively analyzed...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Med
Hlavní autoři: Mo, Hongnan, Hao, Xuezhi, Liu, Yutao, Wang, Lin, Hu, Xingsheng, Xu, Jianping, Yang, Sheng, Xing, Puyuan, Shi, Youwu, Jia, Bo, Wang, Yan, Li, Junling, Wang, Hongyu, Wang, Ziping, Sun, Yan, Shi, Yuankai
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Clinical Cancer Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924370/
https://ncbi.nlm.nih.gov/pubmed/26993156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.689
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky